US Stock MarketDetailed Quotes

IBRX ImmunityBio

Watchlist
  • 2.620
  • -0.050-1.87%
Close Dec 20 16:00 ET
  • 2.650
  • +0.030+1.14%
Post 19:54 ET
1.91BMarket Cap-2.88P/E (TTM)

About ImmunityBio Company

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

Company Profile

SymbolIBRX
Company NameImmunityBio
Listing DateJul 28, 2015
Issue Price25.00
Founded2014
CEOMr. Richard Adcock
MarketNASDAQ
Employees628
Fiscal Year Ends12-31
Address3530 John Hopkins Court
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-844-696-5235
Websitehttp://www.immunitybio.com

Company Executives

  • Name
  • Position
  • Salary
  • Richard Adcock
  • Chief Executive Officer, President and Director
  • 1.16M
  • Dr. Barry J. Simon, M.D.
  • Chief Corporate Affairs Officer and Director
  • --
  • Dr. Patrick Soon-Shiong, F.A.C.S.,M.D.
  • Executive Chairman of the Board, Global Chief Scientific and Medical Officer
  • 865.34K
  • David C. Sachs
  • Chief Financial Officer
  • 1.06M
  • Regan J. Lauer
  • Chief Accounting Officer
  • --
  • Dr. Linda Maxwell, M.B.A.,M.D.
  • Independent Director
  • 487.50K
  • Michael D. Blaszyk
  • Independent Director
  • 510.00K
  • Christobel Selecky
  • Independent Director
  • 470.00K
  • General Sir Wesley Kanne Clark
  • Independent Director
  • 465.00K
  • John Owen Brennan
  • Independent Director
  • 472.50K
  • Cheryl L. Cohen
  • Lead Independent Director
  • 506.25K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List